Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Macrogenics (MGNX) Other Operating Expenses (2021 - 2025)

Macrogenics (MGNX) has disclosed Other Operating Expenses for 5 consecutive years, with $10.1 million as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses rose 84.24% to $10.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.0 million through Dec 2025, up 192.79% year-over-year, with the annual reading at $36.0 million for FY2025, 192.78% up from the prior year.
  • Other Operating Expenses for Q4 2025 was $10.1 million at Macrogenics, down from $11.6 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $11.6 million in Q3 2025, with the low at $17000.0 in Q1 2021.
  • Average Other Operating Expenses over 5 years is $3.3 million, with a median of $2.3 million recorded in 2022.
  • The sharpest move saw Other Operating Expenses surged 10818.18% in 2022, then tumbled 90.9% in 2023.
  • Over 5 years, Other Operating Expenses stood at $947000.0 in 2021, then soared by 89.12% to $1.8 million in 2022, then crashed by 90.9% to $163000.0 in 2023, then surged by 3268.1% to $5.5 million in 2024, then surged by 84.24% to $10.1 million in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $10.1 million, $11.6 million, and $8.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.